Table 3.
Item | SPC replacement, %1 | SEM | P value | |||||
---|---|---|---|---|---|---|---|---|
0 | 33 | 66 | 100 | Linear | Quad. | SPC 0% vs. others | ||
BW, kg | ||||||||
day 0 | 6.3 | 6.4 | 6.4 | 6.4 | 0.4 | 0.807 | 0.964 | 0.854 |
day 10 | 7.9 | 7.8 | 7.4 | 6.9 | 0.4 | 0.015 | 0.568 | 0.101 |
day 22 | 12.5 | 12.6 | 11.6 | 10.3 | 0.9 | 0.003 | 0.218 | 0.098 |
day 35 | 21.4 | 20.9 | 19.3 | 17.3 | 1.2 | 0.001 | 0.376 | 0.021 |
ADG, g/d | ||||||||
Phase 12 | 159 | 139 | 106 | 51 | 27 | 0.007 | 0.522 | 0.065 |
Phase 23 | 384 | 406 | 345 | 286 | 44 | 0.009 | 0.160 | 0.255 |
Phase 34 | 684 | 633 | 596 | 535 | 38 | 0.006 | 0.888 | 0.029 |
Overall | 431 | 414 | 370 | 312 | 27 | 0.001 | 0.379 | 0.020 |
ADFI, g/d | ||||||||
Phase 1 | 211 | 197 | 180 | 126 | 24 | 0.016 | 0.396 | 0.128 |
Phase 2 | 498 | 498 | 458 | 386 | 50 | 0.023 | 0.317 | 0.216 |
Phase 3 | 1,001 | 912 | 874 | 798 | 55 | 0.003 | 0.887 | 0.012 |
Overall | 603 | 566 | 533 | 465 | 39 | 0.002 | 0.585 | 0.020 |
G:F | ||||||||
Phase 1 | 0.72 | 0.68 | 0.67 | 0.52 | 0.09 | 0.042 | 0.357 | 0.192 |
Phase 2 | 0.78 | 0.81 | 0.77 | 0.73 | 0.04 | 0.318 | 0.378 | 0.904 |
Phase 3 | 0.68 | 0.70 | 0.68 | 0.67 | 0.02 | 0.534 | 0.615 | 0.927 |
Overall | 0.72 | 0.73 | 0.69 | 0.66 | 0.02 | 0.013 | 0.188 | 0.332 |
Fecal score | ||||||||
Phase 1 | 3.3 | 3.5 | 3.7 | 3.6 | 0.16 | 0.226 | 0.349 | 0.161 |
Phase 2 | 3.2 | 3.1 | 3.3 | 3.3 | 0.07 | 0.155 | 0.707 | 0.552 |
Phase 3 | 3.0 | 3.0 | 3.0 | 3.1 | 0.02 | 0.399 | 0.122 | 0.639 |
Dietary treatments were supplemented with soy protein concentrate (X-Soy 200, CJ Selecta, MG, Brazil) at four levels replacing animal protein supplements including fish meal, poultry meal, and blood plasma (N = 32 total, n = 8 for each replacement level).
Phase 1, from day 0 to day 10.
Phase 2, from day 10 to day 22.
Phase 3, from day 22 to day 35.